ESC 365 - Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

EAPC Premium Access

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

Session: Poster Session 1 - Heart failure

Topic: Chronic Heart Failure, Other

Event: EuroPrevent 2018

Congress Presentation

6 more presentations in this session

Heart failure - Poster discussant:

Comparative risk of heart failure associated with second-line antidiabetes treatments: analysis of real-world Korean data

Speaker: Doctor K. Ha (Seoul, KR)

Influence of pulmonary rehabilitation on clinical characteristics in patients with chronic heart failure and chronic obstructive pulmonary disease

Speaker: Doctor G. Smyrnova (Kyiv, UA)

Aldosterone plasma level as risk factor of cardiovascular events in long-term chronic heart failure with preserved ejection fraction

Speaker: Associate Professor A. Shevelyok (Donetsk, UA)

The predictors of mid-term heart failure-related mortality rate: a databased analysis

Access the full session

Poster Session 1 - Heart failure

Speakers: Doctor K. Ha, Doctor G. Smyrnova, Associate Professor A. Shevelyok

About the event

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

Congress

ESC 365 is supported by